Posted on 5/15/18
Boston Scientific (BSX) CRM and Electrophysiology Products Overview - Slideshow
The following slide deck was published by Boston Scientific Corporation in conjunction with this event. 119'READ FULL ARTICLE HERE
Posted on 5/15/18
Will athenahealth Be the Next Big Healthcare Deal?
Athenahealth (NASDAQ:ATHN) is trying to bust down barriers so that patients and healthcare providers have easy access to comprehensive electronic healthcare records, but not everyone's happy . . .
Posted on 5/15/18
Unum Therapeutics Provides Business Update
CAMBRIDGE, Mass., May 14, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ:UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies based on its . . .
Posted on 5/15/18
New Scientific Advisors Focused on Cell Therapy in Immuno-Oncology and Autoimmunity Join Intellia Therapeutics
CAMBRIDGE, Mass., May 14, 2018 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology, announced . . .
Posted on 5/14/18
Boston TMS Therapy Center Earns NeuroStar® Gold Circle Provider Status
The TMS Center at Commonwealth Psychology Associates (CPA) is now a Gold Circle Provider of NeuroStar TMS Therapy. Gold Circle Provider status is earned by TMS centers . . .
Posted on 5/14/18
Rhythm Pharmaceuticals Reports First Quarter 2018 Financial Results
BOSTON, May 14, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic . . .
Posted on 5/14/18
Ironwood Pharmaceuticals Sends Letter to Shareholders Highlighting Director Nominees
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), a commercial biotech company, today announced that it has mailed a letter to shareholders highlighting the experience and personal perspectives . . .
Posted on 5/14/18
Better Buy: Ziopharm Oncology, Inc. vs. bluebird bio Inc.
Chimeric antigen receptor T-cell (CAR-T) therapies and gene therapies are hot commodities these days. But some small biotechs developing CAR-T drugs and gene therapies are hotter . . .
Posted on 5/13/18
RXi Pharmaceuticals Enters into Material Transfer Agreement with Iovance Biotherapeutics
RXi Pharmaceuticals Corporation (NASDAQ: RXII) announced today that it has entered into a research collaboration with Iovance Biotherapeutics to evaluate the potential synergies with RXi's novel . . .
Posted on 5/13/18
Evelo Biosciences Closes IPO
CAMBRIDGE, Mass., May 11, 2018 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO) announced the closing of its initial public offering of 5,312,500 shares of common stock . . .
Posted on 5/11/18
Why Acacia Communications, Inc. Fell 27% in April
What happenedStock in optical interconnect products provider Acacia Communications (NASDAQ:ACIA) fell 26.8% in April, according to data from S&P Global Market Intelligence. So whatAcacia's stock slumped . . .
Posted on 5/10/18
Steward Health Care Announces Exclusive Partnership With Soccer Legend Kristine Lilly
Steward Health Care today announced an exclusive partnership with legendary American soccer player, Kristine Lilly. The two-time Olympic Gold Medal winner and two-time World Cup champion . . .
Posted on 5/10/18
Keryx Biopharmaceuticals Announces First Quarter 2018 Financial Results
BOSTON, May 10, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced . . .
Posted on 5/10/18
Why Bristol-Myers Squibb Stock Crashed in April
What happenedShares of the big pharma behemoth Bristol-Myers Squibb (NYSE:BMY) turned in one of their worst months on record in April. Specifically, the drugmaker's shares lost . . .
Posted on 5/10/18
Berkshire Hathaway Annual Meeting 2018: A Mirage Of Feelings
Much like the 1975 Billboard top ten hit song, "Feelings", Warren Buffett and Charlie Munger laid out their feelings on a variety of issues in Omaha . . .
Posted on 5/10/18
Who Else Could Buy athenahealth?
Elliott Management is offering $160 in cash per share for athenahealth (NASDAQ:ATHN), a software company that's reshaping the market for electronic health records. The deal may . . .
Posted on 5/10/18
Greentown Labs Opens the Global Center for Cleantech Innovation
In a celebratory announcement with MassachusettsGovernor Charlie Baker, Lieutenant Governor Karyn Polito, Somerville Mayor Joseph Curtatone, and cleantech leaders from around the region and country, Greentown . . .
Posted on 5/10/18
Collegium Provides Corporate Update
CANTON, Mass., May 09, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today reported its financial results for the first quarter of 2018 and provided a . . .
Posted on 5/9/18
Paratek Pharmaceuticals Reports First Quarter 2018 Financial Results
BOSTON, May 09, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline . . .
Posted on 5/9/18
ImmunoGen: An Extremely Promising ADC Therapeutic Innovator
Choose clients as you would friends. - Charlie MungerImmunoGen (NASDAQ:IMGN) is a highly promising bioscience that is harnessing the power of ADC to deliver the next-generation . . .
Posted on 5/9/18
Bernoulli Announces Best Research Paper Award from AAMI Journal
Bernoulli®, a leader in real-time connected healthcare, is honored to announce that the Editorial Board from Biomedical Instrumentation & Technology (BI&T), the peer-reviewed journal for Association . . .
Posted on 5/8/18
RXi Pharmaceuticals Bolsters Strength of Dermatology Intellectual Property Estate
RXi Pharmaceuticals Corporation (NASDAQ: RXII) a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (sd-rxRNA®) therapeutic platform, announced today . . .
Posted on 5/8/18
Evelo Biosciences Prices IPO
CAMBRIDGE, Mass., May 08, 2018 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO) today announced the pricing of its initial public offering of 5,312,500 shares of common . . .
Posted on 5/8/18
Proteon Therapeutics and Lonza Extend Manufacturing Agreement for Commercial Supply
BASEL, Switzerland and WALTHAM, Mass., May 08, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs . . .
Posted on 5/8/18
GCP Applied Technologies Acquires R.I.W. Limited
GCP Applied Technologies Inc. (NYSE:GCP) announced today that it has acquired U.K.-based R.I.W. Limited

